Cantor Fitzgerald Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Buy
111,011
+856
+0.8% +$100K 0.96% 38
2026
Q1
$13.3M Sell
110,155
-4,946
-4% -$571K 0.98% 39
2025
Q4
$12.1M Sell
115,101
-31,580
-22% -$2.96M 0.9% 40
2025
Q3
$12.3M Sell
146,681
-348
-0.2% -$28.7K 0.84% 45
2025
Q2
$11.6M Sell
147,029
-812
-0.5% -$64.5K 0.82% 50
2025
Q1
$13.3M Sell
147,841
-33,765
-19% -$3.15M 0.97% 43
2024
Q4
$18.1M Buy
181,606
+588
+0.3% +$60.6K 1.25% 24
2024
Q3
$20.6M Buy
181,018
+1,047
+0.6% +$124K 1.4% 19
2024
Q2
$22.3M Sell
179,971
-4,866
-3% -$627K 1.72% 12
2024
Q1
$24.4M Sell
184,837
-5,236
-3% -$645K 1.81% 9
2023
Q4
$20.7M Buy
+190,073
New +$19.7M 1.6% 18
2022
Q1
$28.7M Buy
349,588
+169,536
+94% +$13.4M 1.28% 16
2021
Q4
$13.8M Buy
180,052
+2,958
+2% +$236K 0.84% 28
2021
Q3
$13.3M Buy
177,094
+259
+0.1% +$19.7K 0.98% 29
2021
Q2
$13.8M Buy
+176,835
New +$13.2M 1.01% 25

Other funds holding MRK

Cantor Fitzgerald Investment Advisors's MRK Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors increased its Merck (MRK) stake by 0.78% in Q2 2026, buying an estimated $100K and bringing the position to 111,011 shares worth $14.3M. The position accounts for 0.96% of the portfolio, ranked #38.

Cantor Fitzgerald Investment Advisors first reported a position in MRK in Q2 2021 and has held it in 15 quarters since. The position peaked at $28.7M in Q1 2022. 1,681 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cantor Fitzgerald Investment Advisors held 111,011 shares of Merck worth $14.3M as of Q2 2026.
  • Cantor Fitzgerald Investment Advisors bought 856 Merck shares in Q2 2026, an estimated $100K.
  • Merck made up 0.96% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #38 holding.
  • Cantor Fitzgerald Investment Advisors first reported a position in Merck in Q2 2021 and has held it in 15 quarters since.
  • Cantor Fitzgerald Investment Advisors's Merck position peaked at $28.7M in Q1 2022.
  • 1,681 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.